Summary
Ritter Pharmaceuticals develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases.
Deals Overview
Senior Management
Andrew J. Ritter
President and CEO
All rights reserved. Copyright © 2025 Datasite
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy